Modulation of HLA-G expression

Neoplasma

Volumn 54, Issue 6, 2007, Pages 455-462

  Polakova, K ^a   Bandzuchova, E ^b   Tirpakova, J ^b   Kuba, D ^b   Russ, G ^c  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^c INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

Demethylation; Heat shock; Histone deacetylation; HLA G; Hypoxia

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BUTYRIC ACID; COBALT CHLORIDE; DEFEROXAMINE; DNA; DNA METHYLTRANSFERASE; HISTONE; HISTONE DEACETYLASE INHIBITOR; HLA G ANTIGEN; MESSENGER RNA; VALPROIC ACID; AZACITIDINE; DRUG DERIVATIVE; ENZYME INHIBITOR; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA-G ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL STRAIN; CELL STRAIN JAR; CHORIOCARCINOMA; CONTROLLED STUDY; DEACETYLATION; DEMETHYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; PROTEIN EXPRESSION; RAJI CELL; BIOSYNTHESIS; CELL HYPOXIA; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HEAT; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

AZACITIDINE; BASE SEQUENCE; CELL HYPOXIA; CELL LINE, TUMOR; ENZYME INHIBITORS; EPIGENESIS, GENETIC; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEAT; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VALPROIC ACID;

EID: 38949143784     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. ALGARRA I, CABRERA T, GARRIDO F. The HLA cross road in tumor immunology. Hum Immunol 2000; 61: 65-73.
2. TAIT BD. HLA class I expression on human cancer cells. Implication for effective Immunotherapy. Hum Immunol 2000; 61: 158-165.
3. DAVIES B, HIBY S, GARDNER L, et al. HLA-G expression by tumors. Am J Reprod Immunol 2001; 45: 103-107.
4. ROUAS-FREISS N, MOREAU P, FERRONE S, et al. HLA-G proteins in cancer: Do they provide tumor cells with an escape mechanism? Cancer Res 2005; 65: 10139-10144.
5. CHANG CC, MURPHY SP, FERRONE S. Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms. Hum Immunol 2003; 64: 1057-1063. (Pubitemid 37413715)
6. YAN WH, LIN AF, CHANG CC, FERRONE S. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2′- deoxycytidine. Cell Res 2005; 15: 523-531.
7. CHANG CC, FERRONE S. HLA-G in melanoma: can the current controversies be solved? Semin Cancer Biol 2003; 13: 361-369.
8. CHANG CC, MURPHY SP, FERRONE S. Differential in vivo and in vitro HLA-G expression in melanoma cells: Potential mechanisms. Hum Immunol 2003; 64: 1057-1063. (Pubitemid 37413715)
9. MOREAU P, MOUILLOT G, ROUSSEAU P, et al. HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci USA 2003; 100: 1191-1196.
10. MOUILLOT G, MARCOU C, ROUSSEAU P, et al. HLA-G gene activation in tumor cells involves cis-acting epigenetic changes. Int J Cancer 2005; 113: 928-936.
11. FUKS F. DNA methylation and histone modifications: teaming up to silence genes. Cur Opin Genet Dev 2005; 15: 490-495.
12. MINUCCI S, PELICCI PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments of cancer. Nature Rev Cancer 2006; 6: 38-51. (Pubitemid 43054973)
13. HARRIS AL. Hypoxia- a key regulatory factor in tumor growth. Nature Rev Cancer 2001, 2: 38-47.
14. YOO CB, JONES PA. Epigenetic therapy of cancer: past, present and future. Nature Rev Drug Discovery 2006; 5: 37-50.
15. IBRAHIM EC, MORANGE M, DAUSSET J, et al. Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines. Cell Stress Chaperon 2000; 5: 207-218.
16. MOUILLOT G, MARCOU C, ZIDI I, et al. Hypoxia modulates HLA-G gene expression in tumor cells. Human Immunol 2007; 68: 277-285. (Pubitemid 46509544)
17. NAGAMATSU T, FUJII T, YAMASHITA T, et al. Hypoxia does not reduce HLA-G expression on extravillous cytotrophoblasts. J Reproductive Immunol 2004; 63: 85-95.
18. YANG H, HOSHINO K, SANCHEZ-GONZALEZ B, et al. Antileukemia activity of the combination of 5-aza-2′-deoxycytidine with valproic acid. Leukemia Res 2005; 29: 739-748. (Pubitemid 40779480)
19. LUBBERT M. Combined targeting of the epigenetic silence in leukemia: Cooperating activities of DNA methylation and histone deacetylation inhibitors. Leukemia Res 2005; 29: 727-728.
20. MORA-GARCÍA MdeL, DUENAS-GONZÁLEZ A, HERNÁNDEZ- MONTES J, et al. Up-regulation of HLA class I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid. J Translant Med 2006; 4: 55-69.
21. PAUL P, ROUAS-FREISS N, MOREAU P, et al. HLA-G, -E, -F preworkshop: Tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol 2000; 61: 1177-1195.
22. HANIOKA N, OBIKA N, NISHIMURA M, et al. Inducibility of UDP- glucuronosyltransferase 1As by beta-naphthoflavone in HepG2 cells. Food Chem Toxicol 2006; 44: 1251-1260.
23. POLAKOVA K, BENNINK JR, YEWDELL JW, et al. Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules. Hum Immunol 2003; 64: 256-264.
24. GARAYOA M, MARTÍNEZ A, LEE S, et al. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol 2000; 14: 848-862.
25. PHIEL CJ, ZHANG F, HUANG, EY, et al. Histone deacetylase is a direct target of valpoic acid, a potent anticonvulsant, mood stabilizer and teratogen. J Biol Chem 2001; 39: 36734-36741. (Pubitemid 37384288)
26. ROUAS-FREISS N, BRUEL S, MENIER M, et al. Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis. Int J Cancer 2005; 117: 114-122.
27. YAO YQ, BARLOW DH, SARGENT1 IL. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J Immunol 2005; 175: 8379-8385.